Skip to main content
Atrás
Watch Compare

Yubo International Biotech Ltd

Calidad de datos: 100%
YBGJ
OTC Manufacturing Measuring & Analyzing Instruments
$0.01
$0.00 (0.00%)
Cap. Mercado: 1.62 M
Precio
$0.01
Cap. Mercado
1.62 M
Rango del Día
$0.01 — $0.01
Rango de 52 Semanas
$0.01 — $0.18
Volumen
10,000
Apertura $0.01
Promedio 50D / 200D
$0.01
24.00% below
Promedio 50D / 200D
$0.02
58.33% below

Quick Summary

Puntos Clave

Negative free cash flow of -842,802.0

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)255.99%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net Margin-8736.73%
Op. Margin-9614.64%

Seguridad

Debt / Equity
N/A
Current Ratio0.25
Interest CoverageN/A

Valoración

PE (TTM)
-1.50
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -1.5 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % -8736.7 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 255.99% Revenue Growth (3Y) -85.71%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 12,353.0 Net Income (TTM) -1.08 M
ROE N/A ROA -107.67%
Gross Margin 66.10% Operating Margin -9614.64%
Net Margin -8736.73% Free Cash Flow (TTM) -842,802.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.25
Interest Coverage N/A Asset Turnover 0.01
Working Capital -1.91 M Tangible Book Value -1.71 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.50 Forward P/E N/A
P/B Ratio N/A P/S Ratio 131.06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -52.06%
Market Cap 1.62 M Enterprise Value 1.61 M
Per Share
EPS (Diluted TTM) -0.01 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 78.09%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 12,353.0 3,470.0 604,676.0 104,283.0 —
Net Income -1.08 M -1.98 M -1.20 M -1.20 M -1.54 M
EPS (Diluted) -0.01 -0.02 — — —
Gross Profit 8,165.0 2,648.0 419,185.0 52,652.0 820,647.0
Operating Income -1.19 M -1.77 M -1.19 M -1.21 M -1.54 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 167,581.0 169,875.0 178,312.0 18,098.0 21,401.0
Interest Expense — 50.0 -377.0 229.0 427.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 847,094.0 1.53 M 1.67 M 2.35 M 4.59 M
Total Liabilities 2.79 M 4.83 M 3.51 M 2.91 M 4.72 M
Shareholders' Equity -1.95 M -3.42 M -1.84 M -565,373.0 -131,198.0
Total Debt — — — — —
Cash & Equivalents 8,062.0 7,015.0 6,359.0 18,220.0 27,517.0
Current Assets 667,512.0 682,751.0 725,235.0 750,012.0 1.06 M
Current Liabilities 2.79 M 4.72 M 3.40 M 2.52 M 2.79 M